Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Cash Earnings per Share (CEPS)

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   CEPS(Rs) 68.5854.33-44.2617.0052.46

What is the latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS ?

The latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS is 68.58 based on Mar2026 Consolidated results.
Year Cash Earnings per Share (CEPS)
Mar202668.58
Mar202554.33
Mar2024-44.26
Mar202317.00
Mar202252.46

How is Cash Earnings per Share (CEPS) of GLENMARK PHARMACEUTICALS Trending?

Years Cash Earnings per Share (CEPS) % Change
Mar2026 68.58
26.23
Mar2025 54.33
Positive
Mar2024 -44.26
Negative
Mar2023 17
-67.59
Mar2022 52.46 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Cash Earnings per Share (CEPS) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,097.3 Cr -4.2% -13.5% 17% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,204.0 Cr -1% -5.5% 5.7% Stock Analytics
DIVIS LABORATORIES ₹238,497.0 Cr -2.6% -3.9% 38.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹170,481.0 Cr -1.7% -10.2% 30.5% Stock Analytics
CIPLA ₹108,012.0 Cr 0.9% -3.2% -15.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,207.0 Cr -0.6% 1% -0.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-4.2%

-13.5%

17%

SENSEX

-1.6%

-2.3%

-11.5%


You may also like the below Video Courses